70 related articles for article (PubMed ID: 29264672)
1. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
[TBL] [Abstract][Full Text] [Related]
3. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
Jeune F; Collard M; Augustin J; Guedj N; Marchese U; Rouquette A; Cunha AS; Sebagh M; Pessaux P; Avérous G; Wagner M; Bachet JB; Vaillant JC; Sauvanet A; Gaujoux S
Surgery; 2024 Apr; 175(4):1111-1119. PubMed ID: 38071135
[TBL] [Abstract][Full Text] [Related]
4. Impact of radiological and pathological splenic vein involvement in patients with resectable pancreatic body or tail cancer.
Kuriyama N; Mizuno S; Sakamoto T; Fujimura Y; Yuge T; Noguchi D; Ito T; Hayasaki A; Fujii T; Iizawa Y; Murata Y; Tanemura A; Nagata M; Usui M; Kishiwada M
Langenbecks Arch Surg; 2024 Jan; 409(1):39. PubMed ID: 38224370
[TBL] [Abstract][Full Text] [Related]
5. Splenic vein thrombosis is associated with an increase in pancreas-specific complications and reduced survival in patients undergoing distal pancreatectomy for pancreatic exocrine cancer.
Dedania N; Agrawal N; Winter JM; Koniaris LG; Rosato EL; Sauter PK; Leiby B; Pequignot E; Yeo CJ; Lavu H
J Gastrointest Surg; 2013 Aug; 17(8):1392-8. PubMed ID: 23797883
[TBL] [Abstract][Full Text] [Related]
6. Radiographic duodenal invasion is associated with poor prognosis and early recurrence in patients with pancreatic ductal adenocarcinoma.
Miyazawa M; Hirono S; Kawai M; Okada KI; Kitahata Y; Motobayashi H; Sato M; Yoshimura T; Ueno M; Hayami S; Miyamoto A; Shimizu A; Yamaue H
Eur J Surg Oncol; 2023 Oct; 49(10):106960. PubMed ID: 37353425
[TBL] [Abstract][Full Text] [Related]
7. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant chemoradiotherapy for resectable pancreatic cancer: A retrospective study.
Suto H; Matsukawa H; Fuke T; Nagao M; Ando Y; Oshima M; Yamana H; Kamada H; Kobara H; Okuyama H; Kumamoto K; Okano K
Pancreatology; 2024 May; 24(3):431-436. PubMed ID: 38383175
[TBL] [Abstract][Full Text] [Related]
8. Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas.
Miyata Y; Yonamine N; Fujinuma I; Tsunenari T; Takihata Y; Hakoda H; Nakazawa A; Iwasaki T; Einama T; Togashi J; Tsujimoto H; Ueno H; Beck Y; Kishi Y
Ann Surg Oncol; 2023 Dec; 30(13):8621-8630. PubMed ID: 37658273
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of local treatment for isolated liver metastasis after pancreatectomy in pancreatic ductal adenocarcinoma: A propensity score-matched analysis.
Yun WG; Han Y; Lee M; Cho YJ; Jung HS; Kwon W; Jang JY
J Hepatobiliary Pancreat Sci; 2024 Jan; 31(1):50-60. PubMed ID: 37800313
[TBL] [Abstract][Full Text] [Related]
10. Prediction of postoperative recurrence in resectable pancreatic body/tail adenocarcinoma: a novel risk stratification approach using a CT-based nomogram.
Xie T; Xie X; Liu W; Chen L; Liu K; Zhou Z
Eur Radiol; 2023 Nov; 33(11):7782-7793. PubMed ID: 37624415
[TBL] [Abstract][Full Text] [Related]
11. [Long-Term Survival with Distal Pancreatectomy and Postoperative Chemotherapy in a Patient of Pancreatic Invasive Ductal Adenocarcinoma of the Tail with Peritoneal Dissemination].
Awazu M; Yamamoto Y; Agawa K; Omura N; Nakayama S; Idei Y; Maeda H
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1528-1530. PubMed ID: 38303330
[TBL] [Abstract][Full Text] [Related]
12. Rim Enhancement and Peripancreatic Fat Stranding in Preoperative MDCT as Predictors for Occult Metastasis in PDAC Patients.
Bai X; Wu L; Dai J; Wang K; Shi H; Lu Z; Ji G; Yu J; Xu Q
Acad Radiol; 2023 Dec; 30(12):2954-2961. PubMed ID: 37024338
[TBL] [Abstract][Full Text] [Related]
13. Effect of body fat mass loss on prognosis of radical resection for pancreatic ductal adenocarcinoma based on bioelectrical impedance analysis.
Shibata Y; Sudo T; Tazuma S; Sada H; Tanimine N; Shimada N; Tazawa H; Suzuki T; Onoe T; Shimizu Y; Tashiro H; Yamaguchi A; Takahashi S
BMC Surg; 2024 Jan; 24(1):19. PubMed ID: 38212728
[TBL] [Abstract][Full Text] [Related]
14. Can we rely on contrast-enhanced CT to identify pancreatic ductal adenocarcinoma? A population-based study in sensitivity and factors associated with false negatives.
LeBlanc M; Kang J; Costa AF
Eur Radiol; 2023 Nov; 33(11):7656-7664. PubMed ID: 37266655
[TBL] [Abstract][Full Text] [Related]
15. Oncologic resection of pancreatic cancer with isolated liver metastasis: Favorable outcomes in select patients.
Nagai M; Wright MJ; Ding D; Thompson ED; Javed AA; Weiss MJ; Hruban RH; Yu J; Burkhart RA; He J; Cameron JL; Wolfgang CL; Burns WR
J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):1025-1035. PubMed ID: 36652559
[TBL] [Abstract][Full Text] [Related]
16. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection.
Kiritani S; Ono Y; Takamatsu M; Yoshio S; Miyashita M; Oba A; Sato T; Ito H; Inoue Y; Saiura A; Takahashi Y
Ann Surg Oncol; 2024 Jan; 31(1):514-524. PubMed ID: 37803089
[TBL] [Abstract][Full Text] [Related]
17. Preoperative platelet count and survival prognosis in resected pancreatic ductal adenocarcinoma.
Domínguez I; Crippa S; Thayer SP; Hung YP; Ferrone CR; Warshaw AL; Fernández-Del Castillo C
World J Surg; 2008 Jun; 32(6):1051-6. PubMed ID: 18224462
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic index: A prognostic factor of upfront surgery for body or tail pancreatic ductal adenocarcinoma with vascular involvement-A retrospective study.
Qian L; Li J; Sun Y; Chai W; Deng X; Wang W; Shen B
Cancer Med; 2023 Dec; 12(23):21199-21208. PubMed ID: 37933476
[TBL] [Abstract][Full Text] [Related]
19. Reconsidering resectable oncological conditions in pancreatic tail cancer: A multicenter retrospective study on prognostic factors in pancreatic tail cancer after resection (HOPS Pt-01).
Kimura Y; Nakamura T; Imamura M; Nagayama M; Murakami T; Hayashi T; Kato T; Tanaka K; Yoshida M; Kukita K; Imai K; Yoshida M; Masaki Y; Motoya M; Kuwatani M; Koyama M; Ohnishi H; Takemasa I
Pancreatology; 2024 Feb; 24(1):109-118. PubMed ID: 38103948
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of osteosarcopenia in patients undergoing pancreatic resection for pancreatic ductal adenocarcinoma.
Yanagaki M; Onda S; Gocho T; Igarashi Y; Shirai Y; Okui N; Matsumoto M; Sakamoto T; Haruki K; Ikegami T
Langenbecks Arch Surg; 2024 Apr; 409(1):130. PubMed ID: 38634913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
